Anika Therapeutics Reports Q2 2026 Financial Results

What Happened
Anika Therapeutics, Inc. (ANIK) announced its financial results for the quarter ended June 30, 2026 via a press release dated July 29, 2026. The company furnished this press release as Exhibit 99.1 to its Form 8-K under Item 2.02 (Results of Operations and Financial Condition). The filing notes that the information is furnished (not “filed”) for purposes of Section 18 of the Securities Exchange Act.

Key Details

• Reporting event: financial results for the quarter ended June 30, 2026 (Q2 2026).
• Filing date: Form 8-K furnished on July 29, 2026.
• Exhibit included: Exhibit 99.1 — the company press release announcing the results.
• Technical note: information furnished is not subject to Section 18 liability and is not incorporated by reference except as expressly stated; the filing also includes Inline XBRL cover page data.

Why It Matters
Earnings releases provide the latest data on revenue, profitability, cash position and any updated guidance — all of which can affect short‑term stock performance and investor decisions. Because the Form 8-K furnishes the press release, investors should review Exhibit 99.1 (and the company’s subsequent filings) for the specific revenue, net income, EPS and guidance figures disclosed. Check Anika’s investor relations page or the Exhibit 99.1 press release for the detailed quarterly metrics and management commentary.